What is considered a “product” for patent term extension purposes?

For patent term extension purposes, the term “product” is defined in 35 U.S.C. 156(f) as: The active ingredient of a new human drug, antibiotic drug, or human biological product The active ingredient of a new animal drug or veterinary biological product (with certain limitations on manufacturing processes) Any medical device, food additive, or color additive…

Read More

How does the “first permitted marketing or use” requirement affect patent term extension eligibility?

The “first permitted marketing or use” requirement is a crucial factor in determining eligibility for patent term extension. According to 35 U.S.C. 156(a)(5) and 37 CFR 1.720(e), the approval for commercial marketing or use must generally be the first permitted under the provision of law under which the regulatory review occurred. For human drug products:…

Read More

Are design patents eligible for patent term adjustment?

No, design patents are not eligible for patent term adjustment. According to MPEP 2751: “The patent term adjustment provisions of 35 U.S.C. 154(b) as amended by the American Inventors Protection Act of 1999 apply to original utility and plant patents issuing on applications filed on or after May 29, 2000.“ This statement explicitly mentions utility…

Read More